Ellume
Ellume is a private flu diagnostics company founded in 2010 and headquartered in East Brisbane, Australia, developing regulated diagnostic products under founder and CEO Sean Parsons.
- Company typePrivate
- Founded2010
- HeadquartersEast Brisbane, Australia
- Headcount51–100
- GTM typeB2C
- OfferingHardware or Manufacturing
What Ellume does
Ellume is a private, for-profit flu diagnostics company headquartered in East Brisbane, Australia, founded in 2010 by Sean Parsons, who continues to serve as Founder and CEO. The company develops diagnostic products in the influenza testing category, an area that requires regulatory clearance (FDA, TGA, CE) and operates within a clinically validated medical-device framework.
The company operates at a small commercial scale with 51-100 employees and has raised a single disclosed funding round of $5,000,000 in June 2019 (investors and lead investor unspecified in the available data). The website domain ellumehealth.com signals a health-focused commercial brand. No products, pricing, channel partners, customer logos, or revenue figures are detailed in the input data, and the most recent scrape of the corporate domain returned unrelated content rather than product or pipeline information, indicating a significant primary-source data gap.
The business model is not directly disclosed; as a flu diagnostics company, plausible revenue mechanics include B2B sales to pharmacies, clinics, employers, and government health agencies, and/or direct-to-consumer retail distribution. No go-to-market specifics, contract structures, or pricing tiers are evidenced in the available data, so the revenue model is characterized as assumed rather than confirmed.
Ellume firmographics
Firmographics- Name
- Ellume
- Website
- https://ellumehealth.com
- Company type
- Private
- Founded year
- 2010
- Headcount range
- 51–100 employees
- Short description
- Ellume is a private flu diagnostics company founded in 2010 and headquartered in East Brisbane, Australia, developing regulated diagnostic products under founder and CEO Sean Parsons.
- Ownership category
- akta.pro rank
Ellume industry classification
Industry- Product category
- In-Vitro Diagnostics
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- akta.pro primary industry
- Outbreak Investigation & Incident Management (EOC/ICS) (HLAJABAE)
- akta.pro secondary industries
- Disease Surveillance, Epidemiology & Outbreak Response (BPAIAJAA), General Infectious Disease (HLAKAGAA)
Keywords
Where Ellume is headquartered
LocationHeadquarters
- HQ city
- East Brisbane
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Ellume business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Ellume product offering
Product offeringCore offering
Ellume is a flu diagnostics company that develops and manufactures diagnostic products for the detection of influenza. The company operates as a for-profit private entity headquartered in East Brisbane, Australia, with a workforce of 51-100 employees, and was founded in 2010. Specific product SKUs and detailed feature sets are not enumerated in the available source material.
Differentiator
Problem solved
Functional benefit
Products and services
- Flu diagnostics products
Companies that use Ellume
Customer profileIdeal customer profiles1 record
Ellume technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ellume partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights2 records
Ellume competitors and assessment
Company assessmentDirect peers
- LumiraDx: LumiraDx develops connected point-of-care diagnostic platforms with a respiratory menu (flu, COVID, RSV, Strep). Comparable to Ellume on technology approach and product breadth.
- QuidelOrtho Corporation: QuidelOrtho (formerly Quidel) markets Sofia rapid antigen tests for flu, COVID, and RSV. Closest comparable in product format, customer channel, and regulatory pathway.
- Cue Health: Cue Health produces a connected molecular diagnostic platform for at-home and professional respiratory testing. Closest digital, connected-test competitor to Ellume.
Broad incumbents
- Abbott Diagnostics: Abbott's rapid diagnostics arm (Binax NOW, ID NOW) is the dominant player in point-of-care and at-home respiratory testing, including flu. Direct overlap with Ellume's core market.
- Becton, Dickinson and Company (BD): BD's Veritor System is a major rapid respiratory testing platform used in clinics and pharmacies. Competes head-to-head with Ellume in the professional POC flu-testing segment.
- Roche Diagnostics: Roche offers the cobas Liat PCR system and rapid antigen tests for influenza. A large, well-capitalized incumbent with overlapping respiratory testing offerings.
- QIAGEN: QIAGEN provides QIAstat-Dx multiplex respiratory panels and sample-prep kits, competing with single-pathogen rapid tests like Ellume's by offering broad pathogen detection.
- bioMérieux (BioFire Diagnostics): BioFire's FilmArray multiplex PCR panels are the gold standard for respiratory pathogen testing. Represents the higher-sensitivity, lab-based alternative to Ellume's rapid test.
- Hologic: Hologic's Panther and Aptima molecular systems, along with rapid antigen products, place it in the broader respiratory diagnostics competitive set.
Emerging players
- OraSure Technologies: OraSure develops rapid diagnostic tests including at-home sample collection and infectious disease products. Comparable as a smaller specialty diagnostics player with overlapping infectious-disease focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Ellume financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ellume leadership team
Management profileNumber of profiles
Profiles1 record
Ellume funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ellume M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ellume
What does Ellume do?
Ellume is a flu diagnostics company that develops and manufactures diagnostic products for the detection of influenza. The company operates as a for-profit private entity headquartered in East Brisbane, Australia, with a workforce of 51-100 employees, and was founded in 2010. Specific product SKUs and detailed feature sets are not enumerated in the available source material.
When was Ellume founded?
Ellume was founded in 2010. It employs 51 to 100 people.
Where is Ellume based?
Ellume is headquartered in East Brisbane, Australia, in the Oceania region.
Who are Ellume's main competitors?
Direct peers on record are LumiraDx, QuidelOrtho Corporation and Cue Health. Broad incumbents are Abbott Diagnostics, Becton, Dickinson and Company (BD), Roche Diagnostics, QIAGEN, bioMérieux (BioFire Diagnostics) and Hologic. OraSure Technologies is listed as an emerging player.
Does Ellume have an API?
No public API is recorded for Ellume.
What industry is Ellume in?
Ellume's product category is In-Vitro Diagnostics. Its primary akta.pro industry code is HLAJABAE, Outbreak Investigation & Incident Management (EOC/ICS), with a secondary code of BPAIAJAA, Disease Surveillance, Epidemiology & Outbreak Response. Its NAICS code is 339113.